Literature DB >> 6615938

Eye tracking dysfunction unrelated to clinical state and treatment with haloperidol.

D L Levy, R B Lipton, P S Holzman, J M Davis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6615938

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  5 in total

1.  Smooth-pursuit eye movement dysfunction in schizophrenia: the role of attention and general psychomotor dysfunctions.

Authors:  R Schlenker; R Cohen; P Berg; W Hubman; F Mohr; H Watzl; P Werther
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

Review 2.  DNA markers and biological vulnerability markers in families multiply affected with schizophrenia.

Authors:  D Blackwood; D St Clair; W Muir
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

Review 3.  Pharmacological treatment effects on eye movement control.

Authors:  James L Reilly; Rebekka Lencer; Jeffrey R Bishop; Sarah Keedy; John A Sweeney
Journal:  Brain Cogn       Date:  2008-12       Impact factor: 2.310

Review 4.  Markers of vulnerability in schizophrenia.

Authors:  Maria Ladea; Dan Prelipceanu
Journal:  J Med Life       Date:  2009 Apr-Jun

5.  Ocular convergence deficits in schizophrenia.

Authors:  Mark S Bolding; Adrienne C Lahti; Timothy J Gawne; Kristine B Hopkins; Demet Gurler; Paul D Gamlin
Journal:  Front Psychiatry       Date:  2012-10-17       Impact factor: 4.157
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.